SIRT4 and colorectal carcinoma: Sirt4 is also able to prevent the epithelial–mesenchymal transition (EMT) in CRC cells by upregulating the expression of E-cadherin, which promotes cell–cell adhesion and consequently inhibits tumor invasion and metastasis (35) (Table 1).